Desk›Information Technology› iSERA Lifesciences Ltd
iSERA Lifesciences Ltd
BSE 534920 · NSE ISERA · ISIN INE899M01020 · Group XT · Active
Information Technology › Information Technology › IT - Software › Computers - Software & Consulting
₹143.90
+0.00%
BSE close, 28 August 2026
₹121.01 cr
0.8 cr shares · Micro cap
₹116.69 cr
as published
-2,055.7× · 368.97×
EPS ₹-0.07 · BV ₹0.39
1.36 / 0.26
₹ cr, as filed
18
2 selected · 11%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | +0.0% |
|---|---|
| Against 52-week low | +3,262.1% |
| Day change | +0.00% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.07 |
|---|---|
| Price / earnings | -2,055.71× |
| Price / book | 368.97× |
| Book value — derived, price ÷ P/B | ₹0.39 |
| Return on equity | -18.80% |
| Operating margin | — |
| Net margin | — |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -17.95%
- ROE as published
- -18.80%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | — | -0.34 | -1.60 | — | — |
| Mar-26 · Q | 1.16 | 0.55 | 1.58 | 53.96% | 47.33% |
| FY25-26 | 1.36 | 0.26 | 0.74 | 24.80% | 19.11% |
Quarter on quarter
- Net profit, quarter on quarter
- -161.8%
Disclosure profile 18 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| SAST | 5 |
| AGM / EGM | 2 |
| Newspaper Publication | 2 |
| Outcome | 2 |
| Allotment | 1 |
| Board Meeting | 1 |
| Monitoring Agency | 1 |
| PIT / Insider Policy | 1 |
| Trading Window | 1 |
| Procedural sub-total | 16 |
| Total | 18 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
18 filings · 2 selected · busiest 2026-10-06
Filing rhythm · the twelve most recent
2026-09-072026-10-08
SelectedProcedural
Filings
18 in the window · 5 earlier on record
-
8 October 2026 ·
Code of Conduct under SEBI (PIT) Regulations, 2015
Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Continual Disclosure consequent to Preferential Allotment of ....
Company Update / Code of Conduct under SEBI (PIT) Regulations, 2015 View filing →
-
7 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Archana Lonkar
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
7 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nandkumar Kadam
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
6 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhairyasheel Yadav
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
6 October 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sumeet Dhanraj Garad
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
6 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratap Dadasaheb Deshmukh & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
1 October 2026 ·
Allotment
The Board of Directors of the Company, at its meeting held today i.e. October 01, 2026, has approved the allotment of 1,61,82,800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) ....
Company Update / Allotment of Equity Shares View filing →
-
1 October 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) (The "Company") Held On October 01, 2026.
The Board of Directors of the Company, at its meeting held today i.e. October 01, 2026, has approved the allotment of 1,61,82,800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) ....
Others / Outcome without intimation View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
We are hereby submitting the Consolidated Scrutinizer's Report on E-voting during Annual General Meeting of iSEAR Lifesciences Limited (Formerly Known as Covidh Technologies Limited held ....
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
We hereby submit the proceeding of the 34th AGM
AGM/EGM / AGM View filing →
-
28 September 2026 ·
Closure of Trading Window
We hereby submit the Closure of Trading Window for iSEAR LifeSciences Limited (Formerly Known as Covidh Technologies Limited
Insider Trading / SAST / Closure of Trading Window View filing →
-
7 September 2026 ·
Newspaper Publication
We hereby submit the copy of Newspaper Publication of Public Notice regarding 34th Annual General Meeting ('AGM') of the Company , scheduled to be held on Tuesday, September 29, 2026, at ....
Company Update / Newspaper Publication View filing →
-
2 September 2026 ·
Newspaper Publication
iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.
Company Update / Newspaper Publication View filing →
-
1 September 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 01.09.2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
We hereby informed that Board of Directors of the Company at its meeting held on Tuesday, the 01st September, 2026 discuss the agenda attached herewith.
Others / Outcome without intimation View filing →
-
14 August 2026 ·
Submission Of Monitoring Agency Report For Utilization Of Proceeds Of Rights Issue Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) For The Quarter Ended June 30, 2026.
We hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended ....
Company Update / Monitoring Agency Report View filing →
-
7 August 2026 ·
Un-Audited Financial Results For The Quarter Ended June 30, 2026
We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
Result / Financial Results View filing →
-
7 August 2026 ·
534920 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the Board of Directors of the Company at its meeting held on ....
Board Meeting / Outcome of Board Meeting View filing →
-
3 August 2026 ·
Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday 7, August 2026 Inter-Alia, To Consider, Approve And Take On Record The Unaudited Financial Results Of The Company For The Quarter Ended On June 30, 2026
Isera Lifesciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Board Meeting / Board Meeting View filing →
RSS feed for iSERA Lifesciences Ltd · the 50 most recent filings